← Back to Search

Corticosteroid

Dexamethasone 16mg for Migraine

Phase 4
Waitlist Available
Led By Benjamin Friedman, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Moderate or severe migraine
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights

Study Summary

This trial is looking at whether a lower dose of dexamethasone is as effective as a higher dose of dexamethasone for treating acute migraine.

Eligible Conditions
  • Migraine

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Subjects With Headaches Who Have Sustained Headache Relief for 48 Hours
Secondary outcome measures
Additional Headache Medication in the ED
Number of Days With Headache
Number of Subjects With Headache Who Have Relief Within Two Hours of Medication Administration
+2 more

Trial Design

2Treatment groups
Active Control
Group I: Dexamethasone 16mgActive Control1 Intervention
Dexamethasone 16mg, administered intravenously
Group II: Dexamethasone 4mgActive Control1 Intervention
Dexamethasone 4mg, administered intravenously

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
445 Previous Clinical Trials
582,396 Total Patients Enrolled
10 Trials studying Migraine
1,763 Patients Enrolled for Migraine
Benjamin Friedman, MDPrincipal InvestigatorMontefiore Medical Center
6 Previous Clinical Trials
1,633 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What other research has been conducted concerning the efficacy of Dexamethasone 16mg?

"Presently, 553 studies are in-progress to assess the effects of Dexamethasone 16mg , with 144 at Phase 3. Of those trials, a significant portion is concentrated around Mishawaka, Indiana; however, there remains an aggregate total of 18 618 sites running clinical tests on this medication."

Answered by AI

What indications are most frequently referenced when recommending Dexamethasone 16mg?

"Dexamethasone 16mg is traditionally prescribed to treat ophthalmia and sympathetic. Nonetheless, it can also be applied with success in the treatment of eye-related issues such as branch retinal vein occlusion or macular edema."

Answered by AI

What are the potential risks of consuming Dexamethasone 16mg?

"After an evaluation of the available data, our team has assigned a 3 rating to Dexamethasone 16mg's safety profile. This is primarily due this treatment having been approved by Phase 4 trials."

Answered by AI

Are there open positions in this trial currently accessible to participants?

"According to the clinicaltrials.gov website, this particular study is presently not actively seeking candidates. It was originally posted on December 1st 2019 and last updated on September 21st 2022. While this research endeavour is not enrolling participants at present, there are still 725 other studies that are currently looking for volunteers right now."

Answered by AI

Could you provide an estimate of the cohort size for this experiment?

"Currently, this trial is not open for enrollment. It was initially posted on December 1st 2019 and edited most recently on September 21 2022. In the event that you desire to explore different clinical trials, there are 172 studies actively recruiting patients with migraine and 553 medical trails searching for participants taking Dexamethasone 16mg."

Answered by AI
~39 spots leftby May 2025